Role of resveratrol in cardiovascular and associated diseases

Paper Details

Research Paper 01/02/2021
Views (997)
current_issue_feature_image
publication_file

Role of resveratrol in cardiovascular and associated diseases

Shehnai Basharat, Arooj Saeed, Wajeeha Bashir Baig, Tara Khursheed, Maria Amjad, Hafsa Tahir, Tabussam Tufail
Int. J. Biosci. 18(2), 130-136, February 2021.
Copyright Statement: Copyright 2021; The Author(s).
License: CC BY-NC 4.0

Abstract

Resveratrol is a potent bioactive compound found in fruits and taken as dietary supplements. Due to possessing multiple beneficial properties; anti-oxidant, anti-atherosclerosis, cardioprotective, anti-cholesterolemia and glucose regulation. It combats with globally high mortality and morbidity rate diseases. Resveratrol deals with cardiovascular disease and other associated diseases after the result of ROS accumulation. It seems successful in nutraceutical and pharmaceutical to prevent and treat cancer proliferation, diabetes, diabetic-cardiomyocyte, neuropathy, nephropathy and obesity.

Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. 2017 The role of resveratrol in cancer therapy. International journal of molecular sciences 18(12), 2589.

Elshaer M, Chen Y, Wang XJ, Tang X. 2018 Resveratrol: An overview of its anti-cancer mechanisms. Life sciences 15(207), 340-9.

Zordoky BN, Robertson IM, Dyck JR. 2015. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1(6), 1155-77.

Abdelgawad IY, Grant MK, Zordoky BN. 2019. Leveraging the cardio-protective and anticancer properties of resveratrol in cardio-oncology. Nutrients 11(3), 627.

Ahmet I, Tae HJ, Lakatta EG, Talan M. 2017. Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats. Canadian journal of physiology and pharmacology. 95(3), 268-74.

Mohammed S, Harikumar KB. 2018. Role of Resveratrol in Chemosensitization of Cancer. In Role of Nutraceuticals in Cancer Chemosensitization (p 61-76). Academic Press.

Siddiqui IA, Sanna V, Ahmad N, Sechi M, Mukhtar H. 2015.  Resveratrol nanoformulation for cancer prevention and therapy. Ann. NY Acad. Sci. 1(1), 20-31.

Tabrez S, Jabir NR, Adhami VM, Khan MI, Moulay M, Kamal MA, Mukhtar H. 2020. Nanoencapsulated dietary polyphenols for cancer prevention and treatment: successes and challenges. Nanomedicine. (0).

Guthrie AR, Chow HH, Martinez JA. 2017.  Effects of resveratrol on drug‐and carcinogen‐metabolizing enzymes, implications for cancer prevention. Pharmacology research & perspectives. 5(1), e00294.

Yan F, Sun X, Xu C. 2018. Protective effects of resveratrol improve cardiovascular function in rats with diabetes. Experimental and therapeutic medicine 15(2), 1728-34.

Xia N, Daiber A, Förstermann U, Li H. 2017. Antioxidant effects of resveratrol in the cardiovascular system. British journal of pharmacology 174(12), 1633-46.

Meng X, Zhou J, Zhao CN, Gan RY, Li HB. 2020. Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review. Foods. 9(3), 340.

Fang WJ, Wang CJ, He Y, Zhou YL, Peng XD, Liu SK. 2018.  Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation. Acta Pharmacologica Sinica 39(1), 59-73.

Hosseini H, Koushki M, Khodabandehloo H, Fathi M, Panahi G, Teimouri M, Majidi Z, Meshkani R. 2020. The effect of resveratrol supplementation on C-reactive protein (CRP) in type 2 diabetic patients: Results from a systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. 102251.

Wong RH, Nealon RS, Scholey A, Howe PR. 2016. Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases 26(5), 393-9.

Mankowski RT, You L, Buford TW, Leeuwenburgh C, Manini TM, Schneider S, Qiu P, Anton SD. 2020. Higher dose of resveratrol elevated cardiovascular disease risk biomarker levels in overweight older adults–A pilot study. Experimental Gerontology 131, 110821.

Portillo MP, Fernandez-Quintela A. 2019.  Benefits of Resveratrol Supplementation. MDPI-Multidisciplinary Digital Publishing Institute.

Siddiqui IA, Sanna V, Ahmad N, Sechi M, Mukhtar H. 2015. Resveratrol Nano formulation for cancer prevention and therapy. Annals of the New York Academy of Sciences 1348(1), 20-31.

Kotecha R, Takami A, Espinoza JL. 2016. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 7(32), 52517.

Mohammadshahi M, Haidari F, Soufi FG. 2014. Chronic resveratrol administration improves diabetic cardiomyopathy in part by reducing oxidative stress. Cardiology journal 21(1), 39-46.

Tufail T, Saeed F, Imran M, Arshad MU, Anjum FM, Afzaal M, Bader Ul Ain H, Shahbaz M, Gondal TA, Hussain S. 2018. Biochemical characterization of wheat straw cell wall with special reference to bioactive profile. International journal of food properties 21(1), p 1303-1310.

Tufail T, Saeed F, Arshad MU, Afzaal M, Rasheed R, Bader Ul Ain H, Imran M, Abrar M, Farooq MA, Shahid MZ. 2020. Exploring the effect of cereal bran cell wall on rheological properties of wheat flour. Journal of Food Processing and Preservation 44(3), p e14345.

Truong J. The Cytotoxic Effects of Methylmercury on Cardiomyocytes: A Possible Implication for Heart Diseases? (Doctoral dissertation, University of Ottawa).

Prasad K. 2012. Resveratrol, wine, and  atherosclerosis. International Journal of Angiology. 21(01), 007-18.

Aguirre L, Fernández-Quintela A, Arias N, Portillo MP. 2014. Resveratrol: anti-obesity mechanisms of action. Molecules 19(11), 18632-55.

Related Articles

Evaluation of the effectiveness of some plant extracts against cowpea charcoal rot

Manan Djamila Baikoro*, Dianyagou Paul Ouali, Wendoléan Romain Soalla, Pawindé Elisabeth Zida, Bouma James Neya, Marie Laure Guissou, Int. J. Biosci. 28(6), 118-127, June 2026.

Physicochemical profiling and quality evaluation of commercial mustard oils brands in Bangladesh: Indicators of stability and consumer safety

Umme Salma Nahida, Md. Al-Amin Mia, Afroza Bashar*, Tauhida Tasnim, Marjina Akter, Int. J. Biosci. 28(6), 108-117, June 2026.

Optimizing soybean (Glycine max L. Merr.) performance through rhizobial inoculation and planting density in Kétou, Benin

Mahougnon Charlotte Carmelle Zoundji*, Ibouraïman Balogoun, Pascal Gbenou, Tobi Moriaque Akplo, Carlosse Djeho, Félix Kouélo Alladassi, Int. J. Biosci. 28(6), 99-107, June 2026.

Genetic admixture and the philosophy of diplomacy in central Asia: Evidence from intercultural dialogue, governance and genomic data

Shafee Ur Rehman, Waqar Ahmed Khan, Iqra Jamil, Muhammad Abdullah, Int. J. Biosci. 28(6), 89-98, June 2026.

Synthesizing and integrating environmental awareness and bio-intensive gardening under the Gulayan sa Paaralan (SIBUG) extension project

Violeta F. Collado*, Analyn V. Sagun, Angelina T. Gonzales, Marilyn D. Respicio, Int. J. Biosci. 28(6), 82-88, June 2026.

Diversity of insects related to maize (Zea mays) production in Ferkéssédougou region, Côte d’Ivoire

Fondio Drissa, Dao Hassane, Soro Lacina*, Sib Ollo, Kouadio Roger Hosphade Kouassi, Soro Senan, Yeboue N’guessan Lucie, Int. J. Biosci. 28(6), 75-81, June 2026.

Diuretic activity assessment of an aqueous extract of Zanthoxylum gilletii (Rutaceae) stem bark in rats

Akoua Jeanne Kanga*, Essoi Kouametchi Hermann, Françoise Assamala Fossou, Kacou Jules Marius Djetouan, Kouao Augustin Amonkan, Int. J. Biosci. 28(6), 68-74, June 2026.

Phytochemical investigation and in vitro evaluation of cholinesterase inhibitory and antioxidant properties of Aglaonema hookerianum stems

K. M. Monirul Islam, Simin Shabnam Lopa, Joya Rani, Md. Aslam Sheikh, Md. Golam Sadik*, Int. J. Biosci. 28(6), 60-67, June 2026.